Deputy Chief Executive Officer (Strategic Partnerships) & Senior Consultant
Division of Medical Oncology
Dr Toh is Senior Consultant and Deputy Chief Executive Officer (Strategic Partnerships), Division of Medical Oncology, National Cancer Centre Singapore. He graduated from the University of London, UK with an in-tercalated Bachelor of Science in ‘Infection and Immunity’ from St Mary’s Hospital Medical School and qual-ified as a medical doctor from University of Cambridge, UK. Dr Toh obtained his Fellowship of the Royal Col-lege of Physicians in 2003. He received his medical oncology fellowship training at the Singapore General Hospital, Massachusetts General Hospital, Harvard Medical School, Boston USA, and at the Centre for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. Dr Toh is alumni at the Harvard Busi-ness School General Management Program. He is a recipient of National Senior Clinician Scientist Award in 2017 and National Medical Excellence Award (NMEA) in 2018 and for his pioneering work in cell and immu-notherapy for cancer. Dr Toh led the NMRC LCG VICTORY (Virus-Induced Cancers Translational Oncology and immunologY) grant (2018-2024), and is a recipient of Singapore Translational Research (STaR) Investi-gator Award in 2022 focusing on the translational understanding and therapeutic development for hepato-cellular carcinoma.
Dr Toh is a Professor and College Master at the Duke-NUS Graduate Medical School. He is founder chair-man of the Singapore Society of Oncology Cancer Immunotherapy Consortium, co-founder of the Asia Pa-cific Gastroenterology Cancer Summit (APGCS), and faculty in Cancer Immunology for the European Society of Medical Oncology (ESMO). Dr Toh has published over 150 peer review journal papers to date.